Literature DB >> 8078506

Changes of G1 cyclins, cdk2, and cyclin A during the differentiation of HL60 cells induced by TPA.

J Horiguchi-Yamada1, H Yamada, S Nakada, K Ochi, T Nemoto.   

Abstract

Differentiation induction by 12-o-tetradecanoyl 13-acetate (TPA) results in the growth arrest of HL60 cells in the G1 phase. However, little is known about the changes of cell cycle-regulating genes during this differentiation process. We investigated the changes of mRNA for various cyclins (A, C, D1, D2, D3 and E) and cdk2. Synchronized HL60 cells began to proliferate immediately after release from cell cycle block and cell cycle synchrony was obvious until the second S phase. TPA-treated cells accumulated in G1 phase within 24 h and most of the cells were arrested in this phase at 36 h. The expression of cyclins and cdk2 was studied by Northern blot hybridization of the reverse-transcription polymerase chain reaction (RT-PCR). TPA treatment altered the expression of all genes studied. The expression of cdk2 and cyclin A mRNA was markedly down-regulated. Cyclin E mRNA expression was also prominently down-regulated from 12 h to 36 h, at which time a second increase of its expression was observed in control cells. In contrast, the expression of cyclin D1 mRNA was induced by TPA, while its expression in control cells was undetectable by Northern blot hybridization throughout the cell cycle. Cyclin C expression was faint and fluctuated irrelevant of cell cycle, but its expression in both control and TPA-treated cells was higher than at baseline. Cyclin D2 expression remained stable in control cells and TPA treatment resulted in slight down-regulation at 12 h, but no difference was observed after 24 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078506     DOI: 10.1007/bf00925672

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Association of cdk2 kinase with the transcription factor E2F during S phase.

Authors:  M Pagano; G Draetta; P Jansen-Dürr
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

2.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

3.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

4.  Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.

Authors:  Y Geng; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  Rescue from programmed cell death in leukemic and normal myeloid cells.

Authors:  J Lotem; E J Cragoe; L Sachs
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

6.  Cyclin D1 messenger RNA is inducible by platelet-derived growth factor in cultured fibroblasts.

Authors:  E Surmacz; K Reiss; C Sell; R Baserga
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

7.  Differing responses of G2-related genes during differentiation of HL60 cells induced by TPA or DMSO.

Authors:  J Horiguchi-Yamada; H Yamada
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

8.  Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

Authors:  A Koff; F Cross; A Fisher; J Schumacher; K Leguellec; M Philippe; J M Roberts
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

9.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  12 in total

1.  ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway.

Authors:  Ping Lin; Xicai Sun; Tian Feng; Haifeng Zou; Ying Jiang; Zijun Liu; Dandan Zhao; Xiaoguang Yu
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

2.  Role of cyclins in neuronal differentiation of immortalized hippocampal cells.

Authors:  W Xiong; R Pestell; M R Rosner
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Multiple factors regulating the expression of human thromboxane synthase gene.

Authors:  K D Lee; S J Baek; R F Shen
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

5.  Activation of cyclin E-dependent kinase activity in colorectal cancer.

Authors:  W R Cam; T Masaki; T Y Shiratori; N Kato; M Okamoto; Y Yamaji; K Igarashi; T Sano; M Omata
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

6.  p21(WAF1) is associated with CDK2 and CDK4 protein during HL-60 cell differentiation by TPA treatment.

Authors:  J W Cho; Y W Jeong; K S Kim; J Y Oh; J C Park; J C Lee; W K Baek; S I Suh; M H Suh
Journal:  Cell Prolif       Date:  2001-10       Impact factor: 6.831

7.  A macrolide antibiotic, roxithromycin, inhibits the growth of human myeloid leukemia HL60 cells by producing multinucleate cells.

Authors:  M Nagai; H Yamada; S Nakada; K Ochi; T Nemoto; S Takahara; S Hoshina; J Horiguchi-Yamada
Journal:  Mol Cell Biochem       Date:  1995-03-23       Impact factor: 3.396

8.  Cell cycle control of Schwann cell proliferation: role of cyclin-dependent kinase-2.

Authors:  R Tikoo; G Zanazzi; D Shiffman; J Salzer; M V Chao
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

9.  Biological effects of a relatively low concentration of 1-beta-D-arabinofuranosylcytosine in K562 cells: alterations of the cell cycle, erythroid-differentiation, and apoptosis.

Authors:  H Yamada; J Horiguchi-Yamada; M Nagai; S Takahara; T Sekikawa; T Kawano; K Itoh; S Fukumi; S Iwase
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

10.  Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin.

Authors:  Xiaohui Wang; Yujun Song; Jinsong Ren; Xiaogang Qu
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.